DUBLIN–(BUSINESS WIRE)–The “Asia Pacific MVNO Directory 2022-2023” report has been added to ResearchAndMarkets.com’s offering.
The product is known among industry stalwarts as the most trusted & dependable go-to resource for gaining backdoor access to influential decision-makers holding key positions within MVNO businesses all over the Asia Pacific.
Over the last 15 years since its launch, this flagship product has successfully helped hundreds of telecom businesses establish relationships with MVNOs.
Businesses use MVNO directory for a variety of purposes; business development, sales & marketing, B2B networking, event invitations, and largely as a critical addition to (their) resource library to ascertain speedy access to the whole MVNO industry at fingertips, for example.
Asia Pacific MVNO Directory is carved out as a niche product that specifically helps ‘service providers to mobile virtual operators’ obtain and gain new business. Featuring important operator business info to contacts of key executives holding influential roles, the Directory offers the following information for any mobile operator business across the Asia Pacific:
What’s special about the 2022-2023 edition:
Audience
Those looking to do business with MVNOs e.g. Network Enablers, Hubbing Partners, Interconnection usage providers, Roaming partners, Handset manufacturers, Infra service providers, Chipset Providers, Core Solutions, Digitalisation Experts, Consultants, 4G/5G specialists, Other telecom service providers.
For more information about this report visit https://www.researchandmarkets.com/r/xy4kn1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
SINGAPORE - Media OutReach Newswire - 29 April 2024 - XT, the world's first socially…
LONDON--(BUSINESS WIRE)--#BonteFriedheim--NextEnergy Capital (“NEC”), a leading global renewables manager specialised on the solar+ infrastructure sector,…
H2SITE’s AMMONIA to H2POWER technology for ammonia cracking on-board has received Approval in Principle (AiP)…
Daiichi Sankyo and AstraZeneca’s ENHERTU also demonstrated a clinically meaningful progression-free survival improvement in patients…
Q1 2024 Group sales at $7.4 billion, -20% (-18% at CER) versus prior year Q1…
Hongkong Land sees success in its unique and fully owned tenant-based, community initiative that promotes…